AD Life

Ezetimibe-simvastatin SPC invalid in France for non-compliance with both Articles 3a) and 3c) of Regulation No 469/2009

The Court of appeal of Paris, in a decision on the merits, has ruled that the supplementary protection certificate (“SPC”) covering the combination of ezetimibe and simvastatine is invalidl. The decision was rendered on September 25, 2020, in a case opposing Merck and Teva (free translation available here). This is the first decision in Europe on the merits to be rendered by an appellate court.

AD Life

A new damages record in the French pemetrexed case: 28 million euros

The patentee (belonging to the Eli Lilly group) had, during prosecution, amended its claims relating to the use of “antifolates” combined with other compounds to inhibit tumour growth to “pemetrexed” (an antifolate). The EPO examiner raised a 123(2) EPC objection on the term “pemetrexed”, and the claims were granted with the term “pemetrexed disodium” instead of “antifolates

AD Article

Research, innovation and industrial property: drivers of the French recovery plan

On 3 September, the French government launched a €100 billion recovery plan aimed at reviving the French economy and face the crisis resulting from the Covid-19 pandemic. Presented by the French Prime Minister as Europe’s "most massive" , this plan is based on 3 priorities: ecology (€30 billion), competitiveness (€34 billion) and cohesion (€36 billion)

AD Article

Compulsory licenses granted by public authorities: an application in the Covid-19 crisis in France?

As many laboratories around the world are making every effort to find a treatment for Covid-19 and more clinical trials are conducted, it is worth considering the legal mechanisms that could facilitate the quantitatively and qualitatively sufficient, and financially acceptable, exploitation of patent rights that will prove useful in curbing the epidemic and preventing a new one. In a study published in 2019, WIPO identified 156 countries or territories which provide for the exception regarding compulsory licensing. Such exception allows for the use of a patent without the consent of the owner.

AD Article

World Intellectual Property Day 2020: Innovate for a Green Future

The World Intellectual Property Organization (WIPO) dedicates this Sunday, April 26, 2020 to “green innovation”.

AD Article

The Opposition before the French Patent Office

Today is the day of the “launch” of the opposition procedure before the French Patent Office (“Institut National de la Propriété Intellectuelle” or “INPI”). This procedure is a new way to challenge the validity of a French patent, alongside the claim for invalidity.

AD Article

Publication of Decree No. 2020-225 of March 6, 2020 on the opposition procedure for French patents and setting of the opposition fee

The decree n°2020-225, taken for the application of the ordinance n°2020-116 which creates a right of opposition to French patents, was published in the Official Journal on March 6, 2020.

AD Article

Publication of Ordinance No. 2020-116 of 12 February 2020 creating a right of opposition to French patents

On 13 February 2020, Order No. 2020-116 was published in the Official Journal. It creates a right of opposition to the French patents before the INPI. The content of this ordinance is summarized in the report to the President of the Republic published the same day.

AD Article

Impacts of Decree n° 2020-24 of January 13, 2020 on the management of intellectual property rights: focus on public-private research contracts and the single representative of public entities

Decree n° 2020-24, which replaces Decree No. 2014-1518, modifies the method of appointing single representative mentioned in Article L. 533-1 of the French Research Code (in charge of the management and valorisation of the results co-owned by public entities), broadens their missions, provides which are the public co-owners’ obligations towards such single representative and provides for certain other rules for the management of public co-ownership. These provisions "amount to a co-ownership agreement [between the public co-owners] within the meaning of Article L. 613-32 of the Intellectual Property Code[1]", i.e. they derogate from the rules of Articles L. 613-29 to L. 613-31 of such code.

AD Article

Publication of Decree No. 2020-15: a risky simplification of patent proceedings.

Following the adoption of the PACTE law of May 22, 2019[1], the decree No. 2020-15 dated from January 8, 2020 and "relating to the creation of a provisional patent application and the transformation of a utility certificate application into a patent application", was published in the Official Journal on January 10, 2020.